The Healthcare Disruptors: Impact Amazon & Other Big Tech Companies Are Having on The Healthcare Industry

Why Should You Attend:

With Amazon and other big tech companies moving into healthcare, what are the crucial issues that should be considered? To what extent will they impact the unwieldy U.S. healthcare industry? What about their own financial success? Certainly, their intervention in the healthcare industry will be eventually be graded by their ability to have a significant impact on healthcare pricing. Of the other important issues that healthcare disruptors must address: Can they improve what many perceive as the biggest fundamental challenges for healthcare such as lifestyle behaviors, and socio-economic conditions and, will they support or deflect from a market-driven healthcare model?

Marked by restrictive spending, incompetence, burdensome regulation and increasing difficulties among practically all industry stakeholders, America’s healthcare system has ultimately approached a tipping point. The healthcare industry is facing tentative intrusions by market forces who have disrupted other service industries, from travel to retail to mobile phones. Big tech companies are now creating some innovative healthcare products by using their competitive advantages in data analytics, consumer relationships, artificial intelligence and more. Given its joint venture with Berkshire Hathaway and JP Morgan Chase, Amazon is the most high-profile supposed disruptor known to develop an innovative way to approach healthcare insurance directed at decreasing health care costs and enhancing outcomes and focusing on the combined group's one or so million employees. As its share, Apple has enabled an iPhone that allows users in many health systems immediate access to their own medical record. This effort combines Apple's ongoing heart study with Stanford, testing if wearables can detect serious heart conditions. Two subsidiaries Calico and Verity Life Sciences are formed by Google's parent company, Alphabet particularly to focus on healthcare. As Calico is focusing on the human life span, Verity's attempts are in developing new technology to treat diseases and manage population health. In the meanwhile, some principal healthcare players have begun to find out nonconventional partners to face the ever-increasing healthcare costs. The most recent one that is grabbing the attention is the merger of CVS Health and Aetna to allow more cost-effective and convenient access to care and services.

Areas Covered in the Webinar:

• Evaluate key factors driving healthcare disruption
• Find out why big technology companies are entering the healthcare industry
• Leading characteristics of big tech companies which are propelling their involvement in healthcare
• Discuss the Amazon venture with JP Morgan-Chase and Berkshire-Hathaway and determine why it may be able to finally crack the healthcare cost code
• Overview of other Amazon initiatives to disrupt healthcare
• Summarize major activities of big tech giants Apple and Alphabet activities to disrupt the healthcare industry
• Explain why the health insurance industry is ripe for disruption and what tech companies are doing to enter this sector
• Discover why the new CVS-Aetna venture stands out from other vertical healthcare mergers
• Anticipated market impact from the CVS Aetna merger
• Assess why an increasing number of nontraditional partners will be linking up with key healthcare players
• Outlook for future big tech disruption of healthcare industry

Who Will Benefit:

• C-level executives including Chief Executive Officer (CEO)
• President
• Chief Operating Officer (COO)
• Chief Financial Officer (CFO)
• Chief Technology Officer (CTO)
• Chief Data Officer (CDO)
• Chief Information Officer (CIO)
• Chief Compliance Officer (CCO)
• Chief Knowledge Officer (CKO)
• Chief Medical Officer
• Chief Marketing Officer (CMO)
• Vice President/Director and senior managers of key functional areas including finance, marketing, sales, distribution, acquisitions/mergers, research, planning and business development

Dennis Weissman
President, Dennis Weissman and Associates LLC

Dennis Weissman is a nationally known, independent analyst, consultant, speaker and thought leader for the clinical laboratory and anatomic pathology sectors for the past three decades. He is President of Dennis Weissman & Associates, LLC, Falls Church, VA, a consultancy which provides market intelligence, business leadership, public policy insights and M&A advisory series to diagnostic and life science companies. Mr. Weissman has expertise is Medicare and healthcare reform policies and trends, laboratory and pathology payment and compliance issues as well as business and financial trends affecting the diagnostic other key health care sectors. He regularly speaks on a wide variety of healthcare topics during webinars, seminars and conferences sponsored by professional associations, medical groups and healthcare companies.

Follow us :